SCHEMBL23861497

SCHEMBL23861497

CC(c1ccc(-c2ccc(C(C)(c3c(O)cc(O)c4ccccc34)c3c(O)cc(O)c4ccccc34)cc2)cc1)(c1c(O)cc(O)c2ccccc12)c1c(O)cc(O)c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 2/20 0.42
▸ ESR2 Q92731 2/20 0.42
▸ LMNA P02545 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ MCL1 Q07820 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ NSD2 O96028 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ TRPM4 Q8TD43 1/20 0.37
▸ MPL P40238 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ IDO1 P14902 2/20 0.35
▸ EP300 Q09472 1/20 0.34
▸ KIF11 P52732 1/20 0.34
▸ ALOX5 P09917 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861622 0.95 ESR1 (0.46) ESR1ESR2LMNAHTTMCL1
SCHEMBL23861445 0.89 ESR1 (0.49) ESR1ESR2LMNAHTTMCL1
SCHEMBL23861495 0.79 TRPM4 (0.42) ESR1ESR2MEN1POLBKMT2A
SCHEMBL23861559 0.78 PTPN22 (0.44) ESR1ESR2KDM4EMEN1POLB
SCHEMBL23861498 0.78 LMNA (0.46) ESR1ESR2LMNAHTTMCL1
SCHEMBL19192061 0.77 HTT (0.47) LMNAHTTMCL1KDM4EMEN1
SCHEMBL23861453 0.76 ESR1 (0.42) ESR1ESR2LMNAHTTKDM4E
SCHEMBL19803934 0.76 ESR1 (0.42) ESR1ESR2KDM4EMEN1POLB
SCHEMBL23861624 0.72 TRPM4 (0.46) ESR1ESR2LMNAHTTMEN1
SCHEMBL23861563 0.71 PTPN22 (0.48) ESR1ESR2KDM4EMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 ESR1 713/4885ESR2 1033/4885LMNA 3097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback